NECLIFE Financial Statements

Nectar Lifescience Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (35) 26.10 14.10 (1.90)
Op profit growth (50) (7) 5.23 (6)
EBIT growth (68) (8.20) (3.80) (1.20)
Net profit growth (330) (39) (5.50) 2.02
Profitability ratios (%)        
OPM 7.07 9.28 12.60 13.70
EBIT margin 3.41 6.90 9.48 11.20
Net profit margin (4.70) 1.34 2.79 3.37
RoCE 2.54 7.83 8.64 9.25
RoNW (1.70) 0.72 1.27 1.41
RoA (0.90) 0.38 0.63 0.69
Per share ratios ()        
EPS (3.30) 1.42 2.33 2.47
Dividend per share -- 0.05 0.05 0.05
Cash EPS (6) (1.30) (0.50) (0.30)
Book value per share 47.40 50.70 47.20 44.90
Valuation ratios        
P/E (5.70) 6.96 11.40 14.30
P/CEPS (3.10) (7.70) (49) (114)
P/B 0.39 0.20 0.56 0.78
EV/EBIDTA 11.50 4.37 6.35 6.70
Payout (%)        
Dividend payout -- -- 2.15 2.03
Tax payout (19) (15) (17) (18)
Liquidity ratios        
Debtor days 91.10 77.70 108 110
Inventory days 185 142 167 188
Creditor days (122) (94) (119) (132)
Leverage ratios        
Interest coverage (0.50) (1.30) (1.50) (1.60)
Net debt / equity 0.83 0.67 0.89 0.86
Net debt / op. profit 8.05 3.45 4 3.85
Cost breakup ()        
Material costs (75) (79) (73) (70)
Employee costs (4.80) (3.40) (4.20) (4.80)
Other costs (13) (8.80) (10) (11)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 1,543 2,366 1,876 1,644
yoy growth (%) (35) 26.10 14.10 (1.90)
Raw materials (1,157) (1,859) (1,367) (1,154)
As % of sales 75 78.50 72.90 70.20
Employee costs (73) (81) (78) (79)
As % of sales 4.75 3.42 4.18 4.82
Other costs (204) (207) (195) (186)
As % of sales 13.20 8.75 10.40 11.30
Operating profit 109 220 236 224
OPM 7.07 9.28 12.60 13.70
Depreciation (60) (61) (64) (62)
Interest expense (112) (126) (115) (117)
Other income 3.79 4.36 6.04 22.70
Profit before tax (59) 37.50 62.70 67.40
Taxes 11.50 (5.70) (10) (12)
Tax rate (19) (15) (17) (18)
Minorities and other -- -- -- --
Adj. profit (48) 31.80 52.30 55.30
Exceptional items (25) -- -- --
Net profit (73) 31.80 52.30 55.30
yoy growth (%) (330) (39) (5.50) 2.02
NPM (4.70) 1.34 2.79 3.37
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (59) 37.50 62.70 67.40
Depreciation (60) (61) (64) (62)
Tax paid 11.50 (5.70) (10) (12)
Working capital 276 200 362 185
Other operating items -- -- -- --
Operating cashflow 168 171 349 178
Capital expenditure 646 417 233 79.80
Free cash flow 814 588 583 258
Equity raised 1,812 1,844 1,830 1,835
Investments (4.70) 0.21 0.41 0.32
Debt financing/disposal 425 (222) 77.40 22
Dividends paid -- -- 1.12 1.12
Other items -- -- -- --
Net in cash 3,046 2,210 2,492 2,116
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 22.40 22.40 22.40 22.40
Preference capital -- -- -- --
Reserves 1,040 1,114 1,083 1,036
Net worth 1,062 1,136 1,105 1,059
Minority interest
Debt 903 779 903 955
Deferred tax liabilities (net) 127 125 120 115
Total liabilities 2,093 2,040 2,128 2,129
Fixed assets 871 900 924 952
Intangible assets
Investments 0.69 0.40 0.78 0.78
Deferred tax asset (net) 44.30 8.36 7.65 7.24
Net working capital 1,152 1,110 1,174 1,160
Inventories 588 978 918 859
Inventory Days 139 151 -- 167
Sundry debtors 375 396 559 612
Debtor days 88.60 61.10 -- 119
Other current assets 612 338 282 290
Sundry creditors (391) (566) (531) (539)
Creditor days 92.50 87.30 -- 105
Other current liabilities (32) (36) (53) (62)
Cash 25.50 21.30 21.30 9.31
Total assets 2,093 2,040 2,128 2,129
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 547 513 420 445 408
Excise Duty 71.20 70 55.50 60 58.50
Net Sales 476 443 365 385 349
Other Operating Income 0.01 0.01 0.01 0.01 (0.70)
Other Income 0.52 0.53 5.10 5.15 1.02
Total Income 477 444 370 390 350
Total Expenditure ** 427 396 337 350 345
PBIDT 49.70 47.10 32.60 40.50 4.93
Interest 17.40 17.60 18 25.80 25.70
PBDT 32.20 29.50 14.60 14.80 (21)
Depreciation 14.30 14.30 14.20 14.30 15
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- 8.59
Deferred Tax 6.32 5.49 (1.50) (1.30) (3.30)
Reported Profit After Tax 11.70 9.73 1.86 1.79 (41)
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 11.70 9.73 1.86 1.79 (41)
Extra-ordinary Items -- -- -- -- (19)
Adjusted Profit After Extra-ordinary item 11.70 9.73 1.86 1.79 (22)
EPS (Unit Curr.) 0.52 0.43 0.08 0.08 (1.80)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 22.40 22.40 22.40 22.40 22.40
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 10.40 10.60 8.93 10.50 1.41
PBDTM(%) 6.77 6.66 3.99 3.84 (5.90)
PATM(%) 2.45 2.20 0.51 0.46 (12)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity